[1] |
WEI Manli, LYU Linyan, ZHENG Zhiyuan, YIN Jiye, MAI Zhixiong.
Preclinical genotoxicity evaluation of xueshuantong injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1014-1018.
|
[2] |
ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying.
Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870.
|
[3] |
SUN Yue, HU Xinyue, LI Jing, ZHANG Wei, DING Xiaoli, ZHANG Hui, LIANG Chenggang.
Quality evaluation of desmopressin tablets and injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 632-637.
|
[4] |
DING Xiaoli, HU Xinyue, WANG Xuelei, SUN Yue, LI Jing, ZHANG Hui, Liang Chenggang, WANG Yan.
Quality evaluation of insulin glargine injections
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 644-650.
|
[5] |
LIU Yi, QIN Ling, GUO Xianhui, CHEN Hua, PEI Yusheng.
Applications of TGA and DSC in pharmaceutical analysis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 283-289.
|
[6] |
ZHANG Xiaoming, LYU Ping, HU Xinyue, DING Xiaoli, LI Jing, LIANG Chenggang.
Detection of single-chain precursor residues in insulin glargine by ELISA
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 290-294.
|
[7] |
WEN Hairuo, HUANG Qin, HAN Suqin, JIANG Hua, QIN Chao, SHI Haokun, ZHAO Tingting, GENG Xingchao, WANG Qi.
Mutagenicity risk of N-nitrosobumetanil in SD rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 307-312.
|
[8] |
HUANG Yinyin, ZHANG Liwen, LIU Jing, CHEN Jing, ZHOU Yuanhua, XU Mingzhe, YAO Shangchen, WANG Chen, ZHANG Xianhua.
Preparation, characterization and stability of three forms of prulifloxacin
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 374-378.
|
[9] |
HOU Jinfeng, LI Min, HUANG Xiaochun, KOU Jinping, CHE Baoquan, LIU Haitao, YAO Shangchen.
Determination of contents of erythromycin cyclocarbonate tablets using HPLC method
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1238-1242.
|
[10] |
WEN Hairuo, WANG Yanan, JIANG Hua, WANG Xue, WANG Qi, MA Shuangcheng.
In vivo genotoxic risk assessment of emodin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 635-640.
|
[11] |
HUANG Lu, LIU Bo, WANG Yan, FAN Huihong, ZHANG Qingsheng.
Research progress in quality control of nucleoside antiviral drugs
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 692-696.
|
[12] |
WANG Yue, SONG Yujuan, LIU Qian, ZHAO Xiangmei, DENG Lijuan, FAN Huihong.
Quality evaluation and quality research of domestic hydroxyethyl starch 130/0.4 injection
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1067-1072.
|
[13] |
DUAN Xiying, WANG Dongyun, XU Jia, QIU Yajing, XU Mingzhe.
Determination of Silicon in Pantoprazole Sodium for Injection by ICP-MS
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 611-613.
|
[14] |
GAO Mei, MA Hui, CHEN Kai, ZHANG Daizhou.
Genotoxicity Evaluation of (R)-(+)-Rabeprazole Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 559-563.
|
[15] |
WANG Huiping, WANG Enli, XU Jiaoyan, YAO Jingchun.
Genetic Toxicity of Tongguan san
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 861-866.
|